NOMOS launches IGRT optical camera targeting system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

North American Scientific Inc.'s NOMOS Radiation Oncology Division has launched a new image-guided tracking feature that expands clinical applications for its innovative tumor imaging systems.

Incorporated into the company's BAT (B-mode Acquisition and Targeting) image-guided radiation therapy (IGRT) technology, this new optical camera targeting system expands BAT's clinical capability to image targets for therapeutic radiation treatment not only in the prostate, but also in breast, liver, pancreas, bladder, cervix and head and neck cases.

Working in tandem with the optical camera is a newly developed and patented ultrasound probe tracker that will allow the user to navigate on multiple planes and at multiple angles. The omni-directional probe allows clinicians to image soft tissue structures and their interface with other internal structures, providing the high-quality ultrasound imaging necessary for today's Intensity Modulated Radiation Therapy (IMRT) treatments, as well as conventional therapy.

BAT applications, which previously centered on the prostate, can now be used to locate soft tissue targets anywhere in the body, quickly and easily.

According to North American Scientific, BAT is an image-guided targeting system that provides fast ultrasound localization of a treatment target on a daily basis. Currently, it is most commonly used in conjunction with the treatment of prostate cancer. Combining ultrasound with a 3D tracking system and a touchscreen-based treatment room interface, BAT non-invasively pinpoints tumor targets rapidly and accurately at the time of a radiation therapy treatment. Its ImageSync technology provides a continuous stream of ultrasound images that can be utilized in real-time.